|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The impact of improved compliance with a weekly contraceptive transdermal |
| system (Ortho Evra) on contraceptive efficacy. |
| Archer DF; Cullins V; Creasy GW; Fisher AC |
| Contraception. 2004 Mar;69(3):189-195. |
| The contraceptive efficacy of perfect dosing cycles and imperfect dosing cycles has not been described previously. |
| Method compliance determines the proportion of perfect and imperfect dosing cycles, and together can form the |
| basis for evaluating differences in efficacy based on differences in compliance. The transdermal contraceptive |
| delivery system (Ortho Evra) has been studied in a North American randomized trial vs. an oral contraceptive (OC) and |
| in total has been evaluated in 3319 women in contraceptive clinical trials. This article explores the impact of perfect |
| vs. imperfect compliance with the contraceptive method on contraceptive efficacy. Previously published data for a |
| transdermal system (Patch, n = 812) and OC (Triphasil, n = 605) users from the North American comparative study |
| were reanalyzed to determine the effect of imperfect use on the contraceptive efficacy of the different methods. |
| Contraceptive efficacy was significantly better (p = 0.007) in cycles with perfect dosing (Pearl Index = 0.83) compared |
| to those with imperfect dosing (Pearl Index = 6.32) for both methods. This difference is homogeneous (p = 0.62) |
| across the Patch and OC groups. Pooled data for all Patch users confirm that perfect dosing cycles are associated |
| with significantly better efficacy than imperfect dosing cycles (p = 0.047). In addition, compliance did not vary by age |
| in the pooled Patch data, which are in agreement with the previously published Patch data from the comparative |
| study. In the comparative study, the percentage of cycles with perfect dosing was significantly higher with the Patch |
| than with the OC (88.7% vs. 79.2%, p < 0.001), and was consistently high in all age groups (range, 89.6 -91.8%). By |
| contrast, among OC users, the percentage of cycles with perfect dosing increased with increasing age (p < 0.001) |
| from 67.7% in users aged 18 -20 years to more than 80% in those aged 30 years and older. In conclusion, deviations |
| from perfect use (whether corrected or not) of a transdermal contraceptive system and of an OC increase |
| contraceptive failures by approximately 5-10-fold when compared to perfect use. The weekly change schedule of the |
| transdermal contraceptive delivery system is associated with a significantly greater proportion of cycles in which |
| there is perfect dosing compared to an OC. (PubHealth.info Document ID: CONT1T 571-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The impact of improved compliance with a weekly |
| contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.", is(are) Archer DF; Cullins V; Creasy GW; |
| Fisher AC. The source of this article is "Contraception. 2004 Mar;69(3):189-195.". This article was published in |
| 2004 in English language(s). (PubHealth.info® Document ID: CONT1T 571-06. All rights reserved with |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |